CORRECTION: Oncolytics Biotech Launches Up To $75M At-the-Market Equity Offering With Jefferies To Fund Clinical Development And Operations
On April 6, 2026, Oncolytics Biotech Inc. (the "Company") entered into an Open Market Sale Agreement (the "Sales Agreement") with Jefferies LLC (the "Agent"), pursuant to which the Company may offer and sell from time to
04/06/2026